TLR7 AND TLR8 AGONISTS FOR THE TREATMENT OF CANCER AND/OR INFECTIOUS DISEASES
Disclosed herein are compounds of the Formula (I) or (II) or (III):Also disclosed are methods for stimulating an immune response, inducing an anti-tumor immune response, and treating an infectious disease in a subject by administering a therapeutically effective amount of a compound disclosed herein...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
13.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed herein are compounds of the Formula (I) or (II) or (III):Also disclosed are methods for stimulating an immune response, inducing an anti-tumor immune response, and treating an infectious disease in a subject by administering a therapeutically effective amount of a compound disclosed herein. Also disclosed are methods of treating a tumor or abnormal cell proliferation by administering a therapeutically effective amount of a compound disclosed herein under conditions effective to treat a tumor or abnormal cell proliferation. |
---|---|
Bibliography: | Application Number: US202218547594 |